Biomedicine in the COVID Age: Opportunities, Responses, and Challenges

被引:1
|
作者
Rao, Gundu H. R. [1 ]
机构
[1] Univ Minnesota, Lab Med & Pathol, Thrombosis Res Lillehei Heart Inst, Minneapolis, MN 55455 USA
关键词
SARS-CoV-2; COVID-19; biomedicine; vaccine; CORONAVIRUS DISEASE 2019; COMORBIDITIES; OUTCOMES;
D O I
10.21103/Article11(3)_RA1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
According to one of the earliest definitions, biomedicine means "clinical medicine based on the principles of physiology and biochemistry." Clinicians for quite some time preferred the use of the term medical research to describe what they considered the clinical findings pertaining to various issues related to clinical studies. Since the time when the basic molecules of life, deoxyribonucleic acids, were characterized and the genetic code elucidated, there has been great excitement, anticipation, and promise for the development of precision and personalized medicine. However, the progress has been considerably slow and at times disappointing. The unprecedented coronavirus disease created a worldwide panic and exposed all our weaknesses and unpreparedness. It also demonstrated a global demand for better public health infrastructure and preparedness to combat future pandemics. This unprecedented public health crisis acted as a great stimulus for putting together a concerted effort to develop vaccines. According to the experts, the time was right and within 48 hours after the information on the SARS-CoV-2 genome was posted, Moderna scientists had on paper a workable mRNA, which would code for the spike protein. The immune engineers at Moderna as well as BioNTech were able to put together a lipid nanoparticle delivery system for safe delivery of this precious cargo to the appropriate cells. Professor Cody Meissner at Tufts University School of Medicine in Boston says, "It is absolutely astonishing that this happened [COVID Vaccine development] in such a short time-to me, it is equivalent to putting a person on the Moon." It is indeed a great achievement, and it demonstrated the power of basic science and emerging technologies. The extraordinary success of mRNA vaccines has opened new avenues for mRNA-based therapies. mRNAs, siRNAs, and non-coding miRNAs will play a very important role as novel therapeutics soon. Furthermore, this success has acted as a catalyst for ongoing work on the use of small RNAs for therapeutic purposes. Having said that, I must say that there are a great many challenges that need to be addressed.
引用
下载
收藏
页码:241 / 249
页数:9
相关论文
共 50 条
  • [21] The Age of Synthetic Realities: Challenges and Opportunities
    Cardenuto, Joao Phillipe
    Yang, Jing
    Padilha, Rafael
    Wan, Renjie
    Moreira, Daniel
    Li, Haoliang
    Wang, Shiqi
    Andalo, Fernanda
    Marcel, Sebastien
    Rocha, Anderson
    APSIPA TRANSACTIONS ON SIGNAL AND INFORMATION PROCESSING, 2023, 12 (01)
  • [22] Golden Age of Immunotherapy: Challenges and Opportunities
    Chung, Yeonseok
    Lee, Seung-Woo
    Kim, Wan-Uk
    IMMUNE NETWORK, 2022, 22 (01)
  • [23] Sovereignty in the age of technology: Challenges and Opportunities
    Guitton, Matthieu J.
    COMPUTERS IN HUMAN BEHAVIOR, 2022, 134
  • [24] Opportunities and challenges of radio in the digital age
    Bolea de Anta, Adelaida
    Ferrando Garcia, Pablo
    ADCOMUNICA-REVISTA CIENTIFICA DE ESTRATEGIAS TENDENCIAS E INNOVACION EN COMMUNICACION, 2013, (05): : 19 - 22
  • [25] CHALLENGES AND OPPORTUNITIES IN THE NEW AGE OF MATERIALS
    STUDT, T
    RESEARCH & DEVELOPMENT, 1990, 32 (11): : 56 - &
  • [26] Soil responses to sodicity and salinity: challenges and opportunities
    Oster, JD
    Shainberg, I
    AUSTRALIAN JOURNAL OF SOIL RESEARCH, 2001, 39 (06): : 1219 - 1224
  • [27] Covid-19 and Aging: Challenges and Opportunities
    Rowe, John W.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2022, 77 (07): : 1349 - 1351
  • [28] COVID-19 in France: challenges and opportunities
    不详
    LANCET PUBLIC HEALTH, 2021, 6 (04): : E192 - E192
  • [29] Exosomes and COVID-19: challenges and opportunities
    Babaei G.
    Zare N.
    Mihanfar A.
    Ansari M.H.K.
    Comparative Clinical Pathology, 2022, 31 (2) : 347 - 354
  • [30] Global oncology in the Covid era: Challenges and opportunities
    Mckay, Gary
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 93 - 93